Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Works matching McNaughton, Brian
Results: 13
1
2
Cell surface β‐lactamase recruitment: A facile selection to identify protein–protein interactions.
- Published in:
- Protein Science: A Publication of the Protein Society, 2024, v. 33, n. 4, p. 1, doi. 10.1002/pro.4919
- By:
- Publication type:
- Article
3
Resurfaced cell-penetrating nanobodies: A potentially general scaffold for intracellularly targeted protein discovery.
- Published in:
- Protein Science: A Publication of the Protein Society, 2016, v. 25, n. 6, p. 1129, doi. 10.1002/pro.2926
- By:
- Publication type:
- Article
4
Antibody‐Recruitment as a Therapeutic Strategy: A Brief History and Recent Advances.
- Published in:
- ChemBioChem, 2022, v. 23, n. 16, p. 1, doi. 10.1002/cbic.202200092
- By:
- Publication type:
- Article
5
Computational Hot‐Spot Analysis of the SARS‐CoV‐2 Receptor Binding Domain/ACE2 Complex.
- Published in:
- ChemBioChem, 2021, v. 22, n. 7, p. 1196, doi. 10.1002/cbic.202000562
- By:
- Publication type:
- Article
6
Disparities between Antibody Occupancy, Orientation, and Cytotoxicity in Immunotherapy.
- Published in:
- ChemBioChem, 2020, v. 21, n. 17, p. 2435, doi. 10.1002/cbic.202000083
- By:
- Publication type:
- Article
7
Minimalist Antibodies and Mimetics: An Update and Recent Applications.
- Published in:
- ChemBioChem, 2016, v. 17, n. 20, p. 1892, doi. 10.1002/cbic.201600303
- By:
- Publication type:
- Article
8
Helix-Grafted Pleckstrin Homology Domains Suppress HIV-1 Infection of CD4-Positive Cells.
- Published in:
- ChemBioChem, 2016, v. 17, n. 20, p. 1945, doi. 10.1002/cbic.201600329
- By:
- Publication type:
- Article
9
Back Cover: A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer Cells (ChemBioChem 2/2016).
- Published in:
- ChemBioChem, 2016, v. 17, n. 2, p. 190, doi. 10.1002/cbic.201500679
- By:
- Publication type:
- Article
10
A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer Cells.
- Published in:
- ChemBioChem, 2016, v. 17, n. 2, p. 155, doi. 10.1002/cbic.201500591
- By:
- Publication type:
- Article
11
GLUE That Sticks to HIV: A Helix-Grafted GLUE Protein That Selectively Binds the HIV gp41 N-Terminal Helical Region.
- Published in:
- ChemBioChem, 2015, v. 16, n. 2, p. 219, doi. 10.1002/cbic.201402531
- By:
- Publication type:
- Article
12
A Potent Activator of Melanogenesis Identified from Small-Molecule Screening.
- Published in:
- ChemMedChem, 2009, v. 4, n. 10, p. 1583, doi. 10.1002/cmdc.200900194
- By:
- Publication type:
- Article
13
Structure of HIV TAR in complex with a Lab-Evolved RRM provides insight into duplex RNA recognition and synthesis of a constrained peptide that impairs transcription.
- Published in:
- Nucleic Acids Research, 2018, v. 46, n. 13, p. 6401, doi. 10.1093/nar/gky529
- By:
- Publication type:
- Article